Cigna Corporation (NYSE ... with InvestingPro’s in-depth analysis and exclusive insights on CI. Our Pro platform offers fair value estimates, performance predictions, and risk assessments ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

Discover comprehensive analysis of Cigna and 1,400+ other stocks through detailed Pro Research Reports available on InvestingPro. The new price target of $373 reflects a modest reduction in policy ...

Rice provided insights following a recent investor event at the Evernorth Innovation Lab, hosted alongside Cigna management. According to InvestingPro data, the company currently trades at $315.99, ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...

Boards have increasingly benchmarked against peers as companies release more detailed pay data, per the research.

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

CVS is trading at a trailing 12-month price-to-earnings, a commonly used multiple for valuing healthcare stocks, of 9.65X, ...

Image Source: Silkcharts Meanwhile, Cigna stock’s gain reflects the strong performance of the Evernorth Health Services segment, driven by specialty pharmacy, biosimilars and pharmacy benefit ...

On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE: CI) with a price target of $390.

This was the stock's second consecutive day of losses.